Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (255)

« Back to Publications

Clinical prognostic indicators in multiple system atrophy.

Goh YY. et al, (2026), Brain : a journal of neurology

Wearable Movement-Tracking for Prodromal Parkinson's Disease Detection: A Cross-Country Validation Study.

Kahl F. et al, (2026), Movement disorders : official journal of the Movement Disorder Society

Towards automated joint detection in sleep studies: bridging clinical insight and artificial intelligence

Dorier A. et al, (2026), SLEEP

Serum p‐tau217 Is a Prognostic Indicator of Cognitive Impairment in Idiopathic REM Sleep Behavior Disorder

Yan S. et al, (2026), Annals of Neurology, 99, 912 - 921

Presynaptic dopaminergic imaging as a neurodegeneration staging biomarker in the alpha-synucleinopathy continuum.

Arnaldi D. et al, (2026), European journal of nuclear medicine and molecular imaging

Biomarkers of Leucine-Rich Repeat Kinase 2 (LRRK2) and Lysosomal Dysfunction in Progressive Supranuclear Palsy.

Nielsen L-K. et al, (2026), Movement disorders : official journal of the Movement Disorder Society

Shared Pathogenic Pathways Between REM Sleep Behavior Disorder and Neurodegenerative and Psychiatric Disorders.

Zhang Z. et al, (2026), medRxiv

Divergence of cortical neurophysiology across different neurodegenerative disorders compared to healthy ageing

Trubshaw M. et al, (2026), Progress in Neurobiology, 257, 102865 - 102865

Cholinergic degeneration in prodromal and early Parkinson’s disease: a link to present and future disease states

Eisenstein T. et al, (2026), Brain, 149, 226 - 237

The North American Prodromal Synucleinopathy study: protocol for a multi-site, longitudinal, observational study of idiopathic/isolated rapid eye movement sleep behavior disorder.

Lim MM. et al, (2026), Sleep advances : a journal of the Sleep Research Society, 7

Peripheral and CSF protein quantification in Parkinson's disease and multiple system atrophy-the nucleic acid-linked immuno-sandwich assay.

Vijiaratnam N. et al, (2026), Brain communications, 8

Toward Harmonizing Quantification of Dopamine Neuron Imaging Biomarkers in Parkinson's Disease: The Centamine Scale

Fan Z. et al, (2026), Annals of Neurology

Smartphone-based prediction of dopaminergic deficit in prodromal and manifest Parkinson’s disease

Gunter KM. et al, (2025), npj Digital Medicine, 8

Quantitative measurements of α-synuclein seeds in CSF inform diagnosis of synucleinopathies.

Abdi IY. et al, (2025), Journal of Parkinson's disease, 15, 1412 - 1430

Biomarkers

Mak E. et al, (2025), Alzheimer S Dementia the Journal of the Alzheimer S Association, 21

Load More

1
2
3
4
5
6
7
...
»